|
Status |
Public on Sep 25, 2023 |
Title |
Preclinical quality, safety and efficacy of a human embryonic stem cell-derived product for treatment of people with moderate Parkinson’s Disease (STEM-PD) |
Organism |
Homo sapiens |
Experiment type |
Genome variation profiling by SNP array SNP genotyping by SNP array Other
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation missing |
Has this study been published? Please login to update or notify GEO. |
|
Submission date |
Apr 14, 2023 |
Last update date |
Sep 25, 2023 |
Contact name |
Malin Parmar |
E-mail(s) |
malin.parmar@med.lu.se
|
Organization name |
Wallenberg Neuroscience Center, MultiPark and Lund Stem Cell Centre
|
Department |
Department of Experimental Medical Science, Lund University
|
Street address |
221 84 Lund
|
City |
Lund |
ZIP/Postal code |
Box 117, SE-221 00 |
Country |
Sweden |
|
|
Platforms (3) |
GPL13829 |
Illumina HumanCytoSNP-12 v2.1 BeadChip |
GPL15520 |
Illumina MiSeq (Homo sapiens) |
GPL21697 |
NextSeq 550 (Homo sapiens) |
|
Samples (9)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE229766 |
Preclinical quality, safety and efficacy of a human embryonic stem cell-derived product for treatment of people with moderate Parkinson’s Disease (STEM-PD) I |
GSE229767 |
Preclinical quality, safety and efficacy of a human embryonic stem cell-derived product for treatment of people with moderate Parkinson’s Disease (STEM-PD) II |
GSE229768 |
Preclinical quality, safety and efficacy of a human embryonic stem cell-derived product for treatment of people with moderate Parkinson’s Disease (STEM-PD) III |
|
Relations |
BioProject |
PRJNA955795 |